Literature DB >> 9044833

Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.

J E Hundley1, S K Koester, D A Troyer, S G Hilsenbeck, R E Barrington, J J Windle.   

Abstract

We have used the MMTV-myc and MMTV-ras transgenic mouse mammary tumor models (T. A. Stewart et al., Cell, 38: 627-637, 1984, and E. Sinn et al., Cell, 49: 465-475, 1987) to evaluate how the c-myc and v-Ha-ras oncogenes influence tumor growth characteristics in vivo. MMTV-myc tumors had much higher levels of spontaneous apoptosis than MMTV-ras tumors, whereas intermediate levels were observed in MMTV-myc/ras tumors. Significant differences in cell cycle characteristics were also observed in tumors from mice of the three genotypes. Tumors from MMTV-myc mice had lower G1 and higher S-phase fractions than MMTV-ras tumors, with intermediate values again observed in the MMTV-myc/ras tumors. Despite these differences, however, tumor growth rates for the different groups were similar. These findings highlight the importance of the balance between cell cycle regulation and cell death in determining the kinetics of tumor growth and indicate that distinct oncogenes can have a profound influence on that balance.

Entities:  

Mesh:

Year:  1997        PMID: 9044833

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  c-Myc induction of programmed cell death may contribute to carcinogenesis: a perspective inspired by several concepts of chemical carcinogenesis.

Authors:  Chenguang Wang; Yanhong Tai; Michael P Lisanti; D Joshua Liao
Journal:  Cancer Biol Ther       Date:  2011-04-01       Impact factor: 4.742

2.  MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures.

Authors:  Heidi M Haikala; Juha Klefström; Martin Eilers; Katrin E Wiese
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

Review 3.  Myc and mammary cancer: Myc is a downstream effector of the ErbB2 receptor tyrosine kinase.

Authors:  N E Hynes; H A Lane
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

4.  The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2.

Authors:  X Zeng; F Y Shaikh; M K Harrison; A M Adon; A J Trimboli; K A Carroll; N Sharma; C Timmers; L A Chodosh; G Leone; H I Saavedra
Journal:  Oncogene       Date:  2010-06-28       Impact factor: 9.867

5.  A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis.

Authors:  R E Barrington; M A Subler; E Rands; C A Omer; P J Miller; J E Hundley; S K Koester; D A Troyer; D J Bearss; M W Conner; J B Gibbs; K Hamilton; K S Koblan; S D Mosser; T J O'Neill; M D Schaber; E T Senderak; J J Windle; A Oliff; N E Kohl
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

Review 6.  Of mice and Myc: c-Myc and mammary tumorigenesis.

Authors:  M Hunter Jamerson; Michael D Johnson; Robert B Dickson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

7.  Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.

Authors:  A Calvo; R Catena; M S Noble; D Carbott; I Gil-Bazo; O Gonzalez-Moreno; J-I Huh; R Sharp; T-H Qiu; M R Anver; G Merlino; R B Dickson; M D Johnson; J E Green
Journal:  Oncogene       Date:  2008-05-26       Impact factor: 9.867

Review 8.  Genetically engineered mice as experimental tools to dissect the critical events in breast cancer.

Authors:  Mitchell E Menezes; Swadesh K Das; Luni Emdad; Jolene J Windle; Xiang-Yang Wang; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

9.  Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential.

Authors:  Eran R Andrechek; Robert D Cardiff; Jeffrey T Chang; Michael L Gatza; Chaitanya R Acharya; Anil Potti; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-04       Impact factor: 11.205

Review 10.  Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical models.

Authors:  Christina N Bennett; Jeffrey E Green
Journal:  Breast Cancer Res       Date:  2008-09-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.